Page results
-
We are part of the MRC Centre for Neuromuscular Diseases and our team is actively involved in cutting-edge neuroscience research.
-
This information is to help you understand your forthcoming treatment and contains answers to many frequently asked questions. If you have any questions that this does not answer, or would like…
-
We provide routine histopathological diagnoses using both standard techniques and advanced diagnostics including immunocytochemistry, fluoresent in-situ hybridisation (FISH), and polymerase chain…
-
General urology is now reopen to GP referrals. Should you wish to refer to LUTS or benign prostate services at UCLH, you can do so via the e-referrals service.
-
This page has been written for patients who are having radiotherapy or proton beam therapy to the oesophagus.
-
Communication to clinicians using the biochemistry laboratory service provided by HSL. From 14 April 2025 zinc analyses on blood samples will be changed to state of the art Inductively Coupled Mass Spectrometry (ICP-MS).
-
Information for visitors including visiting times, limit and infection control in place for each ward and location.
-
How to refer to infectious and tropical diseases.
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements